A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
A newly identified microalgae strain, Vischeria magna, produces high levels of EPA omega-3 fatty acids along with vitamins A, E, and C and antioxidant pigments like astaxanthin.
Higher blood DHA levels were linked to lower odds of having both central obesity and depression together, while EPA showed no such link.
A newly designed core-shell nanofiber skin patch steadily released omega-3 fatty acids over 5 days while remaining well-tolerated by skin cells in lab testing.
COVID-19 patients with higher blood omega-3 levels had lower odds of death and hospitalization, while higher vitamin D was linked to shorter hospital stays.
In human liver and intestinal cell models, EPA and DHA altered gene activity in ways that reduced bile acid buildup and toxicity.
In cell and mouse studies, combining omega-3 fatty acids with the drug rapamycin increased cancer cell death and reduced the drug's metabolic side effects.